Rising national prevalence of life-limiting conditions in children in England.

Preferred place of death for children and young people with life-limiting and life-threatening conditions: a systematic review of the literature and recommendations for future inquiry and policy. Palliat Med (2013) 0.87

Paediatric palliative care: development and pilot study of a 'Directory' of life-limiting conditions. BMC Palliat Care (2013) 0.82

Estimating the prevalence of chronic conditions in children who die in England, Scotland and Wales: a data linkage cohort study. BMJ Open (2014) 0.80

Reported availability and gaps of pediatric palliative care in low- and middle-income countries: a systematic review of published data. J Palliat Med (2014) 0.79

Models of reablement evaluation (MoRE): a study protocol of a quasi-experimental mixed methods evaluation of reablement services in England. BMC Health Serv Res (2016) 0.79

Transforming children's palliative care-from ideas to action: highlights from the first ICPCN conference on children's palliative care. Ecancermedicalscience (2014) 0.79

Parents' perspectives of the transition to home when a child has complex technological health care needs. Int J Integr Care (2015) 0.78

Evidence-based planning and costing palliative care services for children: novel multi-method epidemiological and economic exemplar. BMC Palliat Care (2013) 0.78

Conflict escalation in paediatric services: findings from a qualitative study. Arch Dis Child (2015) 0.78

Place of death in children and young people with cancer and implications for end of life care: a population-based study in England, 1993-2014. BMC Cancer (2016) 0.76

The Role of Care Coordinator for Children with Complex Care Needs: A Systematic Review. Int J Integr Care (2016) 0.75

Health-related quality-of-life outcome measures in paediatric palliative care: A systematic review of psychometric properties and feasibility of use. Palliat Med (2016) 0.75

'Why does it happen like this?' Consulting with users and providers prior to an evaluation of services for children with life limiting conditions and their families. J Child Health Care (2013) 0.75

Up against the System: A Case Study of Young Adult Perspectives Transitioning from Pediatric Palliative Care. Nurs Res Pract (2013) 0.75

Identifying the key elements of an education package to up-skill multidisciplinary adult specialist palliative care teams caring for young adults with life-limiting conditions: an online Delphi study. BMJ Support Palliat Care (2014) 0.75

Paediatric palliative care at home: a single centre's experience. Singapore Med J (2016) 0.75

Volunteer activity in specialist paediatric palliative care: a national survey. BMJ Support Palliat Care (2013) 0.75

Development and evaluation of a community respiratory physiotherapy service for children with severe neurodisability. BMJ Qual Improv Rep (2015) 0.75

The 'placement' of people with profound impairments across the lifespan: re-thinking age criteria. BMC Med (2014) 0.75

The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic review. Palliat Med (2016) 0.75

Pediatric palliative care: a reflection on terminology. Palliat Care (2013) 0.75

Pain therapy, pediatric palliative care and end-of-life care: training, experience, and reactions of pediatric residents in Italy. Eur J Pediatr (2014) 0.75

Interventional radiology in paediatric palliative care. Pediatr Radiol (2014) 0.75

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol (2002) 16.75

Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med (2009) 9.35

A simple spreadsheet-based, MIAME-supportive format for microarray data: MAGE-TAB. BMC Bioinformatics (2006) 7.53

Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA (2002) 6.48

Pattern separation in the human hippocampal CA3 and dentate gyrus. Science (2008) 5.56

Risk factors for congenital anomaly in a multiethnic birth cohort: an analysis of the Born in Bradford study. Lancet (2013) 4.96

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science (2008) 4.50

The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?". OMICS (2008) 4.15

The Functional Genomics Experiment model (FuGE): an extensible framework for standards in functional genomics. Nat Biotechnol (2007) 3.55

Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv (2007) 3.38

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology (2003) 2.61

Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet (2008) 2.53

Childhood cancer and population mixing. Am J Epidemiol (2003) 2.52

Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol (2006) 2.43

Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia. Blood (2010) 2.38

Mobile phone use and risk of glioma in adults: case-control study. BMJ (2006) 2.20

Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways. J Virol (2009) 2.19

Clinically validated genotype analysis: guiding principles and statistical concerns. Antivir Ther (2004) 2.14

Organizational Readiness for Change and opinions toward treatment innovations. J Subst Abuse Treat (2007) 2.14

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet (2013) 2.11

Paediatric index of mortality 3: an updated model for predicting mortality in pediatric intensive care*. Pediatr Crit Care Med (2013) 2.08

Vision impairment and dual sensory problems in middle age. Ophthalmic Physiol Opt (2014) 2.04

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology (2011) 2.01

The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction (2002) 1.94

Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis (2007) 1.93

Intracranial pressure complicating severe traumatic brain injury in children: monitoring and management. Intensive Care Med (2006) 1.79

Effect of specialist retrieval teams on outcomes in children admitted to paediatric intensive care units in England and Wales: a retrospective cohort study. Lancet (2010) 1.74

Image-based estimation of ventricular fiber orientations for personalized modeling of cardiac electrophysiology. IEEE Trans Med Imaging (2012) 1.72

Detecting small-area similarities in the epidemiology of childhood acute lymphoblastic leukemia and diabetes mellitus, type 1: a Bayesian approach. Am J Epidemiol (2005) 1.71

A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68

Pediatric palliative care provision around the world: a systematic review. Pediatr Blood Cancer (2011) 1.68

Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J (2010) 1.67

Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults. Diabetes Care (2008) 1.66

Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug Alcohol Depend (2007) 1.64

A chloroplast transgenic approach to hyper-express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol J (2003) 1.64

Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish. Arch Intern Med (2010) 1.64

Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther (2003) 1.63

The theory of planned behavior and healthy eating. Health Psychol (2002) 1.61

Components of socioeconomic risk associated with head and neck cancer: a population-based case-control study in Scotland. Br J Oral Maxillofac Surg (2009) 1.60

Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol Dial Transplant (2008) 1.52

High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol (2013) 1.50

ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease. Atherosclerosis (2002) 1.49

Effects of out-of-hours and winter admissions and number of patients per unit on mortality in pediatric intensive care. J Pediatr (2013) 1.49

Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. J Acquir Immune Defic Syndr (2013) 1.48

Opioid use in palliative care of children and young people with cancer. J Pediatr (2007) 1.48

Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res (2006) 1.47

In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther (2007) 1.46

Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia. Cardiology (2011) 1.46

Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA (2012) 1.45

Weight-for-age distribution and case-mix adjusted outcomes of 14,307 paediatric intensive care admissions. Intensive Care Med (2014) 1.44

Prediction of raised intracranial pressure complicating severe traumatic brain injury in children: implications for trial design. Pediatr Crit Care Med (2008) 1.44

The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. J Mol Med (Berl) (2006) 1.42

Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein. J Virol (2007) 1.41

FuGE: Functional Genomics Experiment Object Model. OMICS (2006) 1.39

The Oak Ridge Polycystic Kidney mouse: modeling ciliopathies of mice and men. Dev Dyn (2008) 1.36

The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration. J Am Coll Cardiol (2010) 1.36

Does glycemic variability impact mood and quality of life? Diabetes Technol Ther (2012) 1.35

Lead toxicity in a 14-year-old female with retained bullet fragments. Pediatrics (2006) 1.34

A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients. J Virol (2005) 1.32

Chromosomal location plays a role in regulation of aflatoxin gene expression in Aspergillus parasiticus. Appl Environ Microbiol (2002) 1.31

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1. Gastroenterology (2003) 1.31

Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay. J Immunol Methods (2004) 1.29

Hypertriglyceridemia and cardiovascular risk reduction. Clin Ther (2007) 1.28

Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol (2011) 1.26

Annotare--a tool for annotating high-throughput biomedical investigations and resulting data. Bioinformatics (2010) 1.26

Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV. Antivir Ther (2005) 1.25

Homocysteine and depression in later life. Arch Gen Psychiatry (2008) 1.24

Brief strategic family therapy versus treatment as usual: results of a multisite randomized trial for substance using adolescents. J Consult Clin Psychol (2011) 1.23

Place and provision of palliative care for children with progressive cancer: a study by the Paediatric Oncology Nurses' Forum/United Kingdom Children's Cancer Study Group Palliative Care Working Group. J Clin Oncol (2007) 1.22

History of allergies and risk of glioma in adults. Int J Cancer (2006) 1.21

Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP). Drug Alcohol Depend (2003) 1.19

Long-term user perceptions of an implanted neuroprosthesis for exercise, standing, and transfers after spinal cord injury. J Rehabil Res Dev (2003) 1.19

Can the Theory of Planned Behaviour mediate the effects of age, gender and multidimensional health locus of control? Br J Health Psychol (2002) 1.18

Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. J Addict Med (2008) 1.18

Accuracy of joint aspiration for the preoperative diagnosis of infection in total hip arthroplasty. J Arthroplasty (2006) 1.18

Ethyl glucuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol Alcohol (2004) 1.17

Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis (2010) 1.17

Interaction between 5 genetic variants and allergy in glioma risk. Am J Epidemiol (2010) 1.16

The use of social-networking sites in medical education. Med Teach (2013) 1.16

Bath salts as a "legal high". Am J Med (2011) 1.15

A randomised controlled 8-week crossover clinical evaluation of the 3M Coban 2 Layer Compression System versus Profore to evaluate the product performance in patients with venous leg ulcers. Int Wound J (2008) 1.15

Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients. Antivir Ther (2004) 1.14

Hearing in middle age: a population snapshot of 40- to 69-year olds in the United Kingdom. Ear Hear (2014) 1.13

Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study. Am Heart J (2012) 1.12

Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res (2009) 1.12

Tailoring cannabis dependence treatment for a diverse population. Addiction (2002) 1.12

Progressive resistance training after stroke: effects on muscle strength, muscle tone, gait performance and perceived participation. J Rehabil Med (2008) 1.11

UK-born Pakistani-origin infants are relatively more adipose than white British infants: findings from 8704 mother-offspring pairs in the Born-in-Bradford prospective birth cohort. J Epidemiol Community Health (2013) 1.10

Successful mental health aging: results from a longitudinal study of older Australian men. Am J Geriatr Psychiatry (2006) 1.10

Disease trajectories and ACT/RCPCH categories in paediatric palliative care. Palliat Med (2010) 1.10

Comparing implementation intention interventions in relation to young adults' intake of fruit and vegetables. Psychol Health (2009) 1.09

Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol (2011) 1.09

Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer (2013) 1.09